199
Views
3
CrossRef citations to date
0
Altmetric
Articles

Identification of new dual spleen tyrosine kinase (Syk) and phosphoionositide-3-kinase δ (PI3Kδ) inhibitors using ligand and structure-based integrated ideal pharmacophore models

&
Pages 469-499 | Received 31 Mar 2016, Accepted 01 Jul 2016, Published online: 19 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sankar Muthumanickam, Balajee Ramachandran, Pandi Boomi, Jeyaraman Jeyakanthan, Halliah Gurumallesh Prabu, Sonamuthu Jegatheswaran & Kumpati Premkumar. (2023) Combination of bendamustine-azacitidine against Syk target of breast cancer: an in silico study. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now

Articles from other publishers (2)

Aimen K. Aljoundi, Clement Agoni, Fisayo A. Olotu & Mahmoud E.S. Soliman. (2019) Turning to Computer-aided Drug Design in the Treatment of Diffuse Large B-cell Lymphoma: Has it been Helpful?. Anti-Cancer Agents in Medicinal Chemistry 19:11, pages 1325-1339.
Crossref
Amit Kumar Halder & M. Natália Dias Soeiro Cordeiro. (2019) Development of Multi-Target Chemometric Models for the Inhibition of Class I PI3K Enzyme Isoforms: A Case Study Using QSAR-Co Tool. International Journal of Molecular Sciences 20:17, pages 4191.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.